Humana (HUM) Scheduled to Post Earnings on Wednesday

Humana (NYSE:HUM) is scheduled to be announcing its earnings results before the market opens on Wednesday, October 30th. Analysts expect the company to announce earnings of $3.54 per share for the quarter. Humana has set its FY24 guidance at $16.00 EPS.Persons that wish to listen to the company’s earnings conference call can do so using this link.

Humana (NYSE:HUM) last announced its quarterly earnings results on Wednesday, July 31st. The insurance provider reported $6.96 EPS for the quarter, beating analysts’ consensus estimates of $5.89 by $1.07. Humana had a return on equity of 16.12% and a net margin of 1.53%. The company had revenue of $29.54 billion during the quarter, compared to analysts’ expectations of $28.52 billion. During the same period in the prior year, the company earned $8.94 EPS. Humana’s revenue was up 10.4% compared to the same quarter last year. On average, analysts expect Humana to post $16 EPS for the current fiscal year and $20 EPS for the next fiscal year.

Humana Stock Performance

Humana stock opened at $262.30 on Wednesday. The company has a market capitalization of $31.61 billion, a P/E ratio of 16.33, a P/E/G ratio of 1.91 and a beta of 0.50. The business has a 50 day moving average of $312.24 and a 200-day moving average of $337.81. The company has a debt-to-equity ratio of 0.70, a current ratio of 1.66 and a quick ratio of 1.66. Humana has a 1 year low of $213.31 and a 1 year high of $527.18.

Humana Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, October 25th. Stockholders of record on Monday, September 30th will be given a $0.885 dividend. The ex-dividend date is Monday, September 30th. This represents a $3.54 dividend on an annualized basis and a dividend yield of 1.35%. Humana’s dividend payout ratio (DPR) is currently 22.04%.

Wall Street Analysts Forecast Growth

A number of analysts have commented on the stock. Stephens reaffirmed an “equal weight” rating and set a $250.00 price target on shares of Humana in a research report on Wednesday, October 9th. Barclays reduced their price objective on shares of Humana from $364.00 to $250.00 and set an “equal weight” rating for the company in a research report on Thursday, October 10th. Leerink Partnrs downgraded shares of Humana from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, October 2nd. Bank of America cut shares of Humana from a “neutral” rating to an “underperform” rating and cut their price objective for the stock from $376.00 to $247.00 in a research report on Wednesday, October 2nd. Finally, Deutsche Bank Aktiengesellschaft decreased their target price on Humana from $349.00 to $250.00 and set a “hold” rating for the company in a research report on Thursday, October 3rd. One investment analyst has rated the stock with a sell rating, nineteen have issued a hold rating and six have given a buy rating to the company’s stock. According to MarketBeat, Humana has an average rating of “Hold” and an average target price of $315.33.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.